← All trials
NCT03372122
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 13, 2017
- Primary completion
- Jan 8, 2018
- Completion date
- Mar 7, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 32
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Molnlycke Health Care ABLead sponsor
- Bio-Science LaboratoriesOverall official - principal investigator
- Molnlycke Health Care ABSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.